Check patentability & draft patents in minutes with Patsnap Eureka AI!

Application of SCML2 in diagnosis and treatment of gastroenteropancreatic neuroendocrine tumors

A neuroendocrine and gastrointestinal technology, applied in the field of biomedicine, can solve problems such as no relevant literature reports, and achieve highly specific effects

Active Publication Date: 2017-06-13
AFFILIATED HOSPITAL OF NANTONG UNIV
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] At present, the detection of SCML2 in GEP-NETs tissue or serum has not been reported in the literature at home and abroad

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of SCML2 in diagnosis and treatment of gastroenteropancreatic neuroendocrine tumors
  • Application of SCML2 in diagnosis and treatment of gastroenteropancreatic neuroendocrine tumors
  • Application of SCML2 in diagnosis and treatment of gastroenteropancreatic neuroendocrine tumors

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0092] Example 1: Research materials and specimens

[0093] 1. Tissue specimen collection

[0094] Sixty-four paraffin sections of GEP-NETs and corresponding paracancerous tissues were collected from the Affiliated Hospital of Nantong University between January 2009 and January 2014, which were confirmed by pathology. All patients did not receive chemotherapy, radiotherapy and hormone therapy before operation. Tumor classification was in accordance with WHO (2010) classification criteria for neuroendocrine tumors, and pathological grading was based on cell proliferation activity and mitotic index. The clinical data of the patients were collected in the medical record room archives, including age, tumor size, clinical stage, pathological features, and operation time. Among them, there were 36 males and 28 females; 38 patients were ≤60 years old, 26 patients were >60 years old; 10 patients had tumors in the esophagus / stomach, 40 intestinal tracts, and 14 pancreatic tumors; 50 ...

Embodiment 2

[0098] Example 2: Immunohistochemical detection of SCML2 in tissues

[0099] 1. Immunohistochemical experiment process (two-step method)

[0100] (1) Treatment of new slides and coverslips: Soak the new slides and coverslips in the acid tank for at least 24 hours, fully rinse with running water and ddH 2 After rinsing three times, soak it in 95% alcohol for at least 24 hours, and dry the cleaned glass slides in an electric constant temperature drying oven. In addition, the glass slides should be treated as follows to prevent detachment: immerse them in the APES working solution (that is, the APES concentrated solution is diluted with acetone at 1:50) and stay for 20-30 seconds, and use ddH 2 O wash away the residual APES, and then put it in a fume hood to dry. The processed slides are stored in slide boxes for future use.

[0101] (2) Slicing and baking: the required tumor tissue is dipped in wax, embedded into a wax block, and cut into thin slices with a thickness of 4-5 μ...

Embodiment 3

[0131] Embodiment 3: ELISA method detects the SCML2 in serum

[0132] 1. The steps of detecting CSML2 in serum by direct ELISA method

[0133] (I) Coating: Take the serum to be tested and add it to a 96-well microtiter plate, 50 μl / well, overnight at 4°C;

[0134] (II) Blocking: Discard the coated serum, wash 3 times with 300 μl / well of washing solution (PBS-0.05% Tween20), add 200 μl / well of blocking solution (PBS-1% BSA), and incubate at 37°C for 1 hour;

[0135] (Ⅲ) Discard the blocking solution, wash once with 300 μl / well of washing solution (PBS-0.05% Tween20), add 100 μl / well of mouse anti-human SCML2 monoclonal antibody (diluted 1:30), and incubate at 37°C for 1 hour;

[0136] (IV) Discard the antibody, wash 3 times with 300 μl / well of washing solution (PBS-0.05% Tween20), add diluted goat anti-mouse IgG-HRP (1:1000 dilution) 100 μl / well, and incubate at 37°C for 1 hour ;

[0137] (V) Discard the antibody, wash 3 times with 300 μl / well of washing solution (PBS-0.05% ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
thicknessaaaaaaaaaa
Login to View More

Abstract

The invention relates to application of Sex Comb on Midleg Like-2 (SCML2) in diagnosis and treatment of gastrointestinal pancreatic neuroendocrine tumors (GEP-NETs). Particularly, SCML2 presents specific expression in tissues of the GEP-NETs, 100% of the GEP-NETs can be diagnosed through combination of SCML2 and Syn or CgA in tissues through immunohistochemical detection, and the detection of serum SCML2 has relatively high specificity to the diagnosis of the NETs. Besides, the invention further establishes an ELISA method for detecting the serum SCML2 level.

Description

technical field [0001] The invention belongs to the technical field of biomedicine, and in particular relates to an application of SCML2 in the diagnosis of gastroenteropancreatic neuroendocrine tumors. Background technique [0002] Neuroendocrine tumors (NETs) can occur in various parts of the body, among which the gastrointestinal tract and pancreas are the most common, and NETs occurring in these parts are collectively referred to as gastroenteropancreatic neuroendocrine tumors (GEP-NETs). Compared with clinically common tumors, GEP-NETs are relatively rare (according to statistics, the incidence rates of pancreas and gastrointestinal tract are 1:100,000 and 1.95-2.5:100,000, respectively). In recent years, with the improvement of clinical diagnosis level and the actual incidence of NETs Epidemiology shows that the incidence rate has increased by about 5 times compared with 30 years ago. Despite the improvement of diagnostic tools and the improvement of understanding of ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): G01N33/574G01N33/577
CPCG01N33/57438G01N33/57446G01N33/577
Inventor 肖明兵鲍柏军吴红培倪润洲江枫陆翠华倪温慨朱净郁莉莉
Owner AFFILIATED HOSPITAL OF NANTONG UNIV
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More